Semiconductors and Semiconductor Equipment
Company Overview of Rayvio Corporation
Rayvio Corporation develops ultraviolet light-emitting diodes for water purification and disinfection. The company was founded in 2013 and is based in the United States.
Key Executives for Rayvio Corporation
Compensation as of Fiscal Year 2016.
Rayvio Corporation Key Developments
RayVio Corp. Delivers 60mW UV LED in Volume
Jan 4 17
RayVio Corp. announced that it is delivering 60mW UV LED in volume. The performance from the company's XP Series is making the use of ultraviolet LEDs for critical medical and public health solutions a reality. With RayVio's XP Series, disinfection of flowing water, whole room sterilization and purification of household products and medical instruments can be achieved safely and efficiently without the use of fragile and hazardous mercury lamps. Even "superbugs" like MRSA can be safely and effectively rendered harmless. With the 60mW output from RayVio's XP Series, it is finally possible to address some larger scale infrastructure problems, like the disinfection of running water with a safe, efficient and long-lasting solution.
RayVio Corp Launches its XE Series of Medium-Power Ultraviolet LEDs
Nov 15 16
RayVio Corp. announced that it has launched its XE Series of medium-power ultraviolet (UV) LEDs that are rated to 6 milliwatts (mW) of output from an ultra-compact 3,535 package. With spectral output of both 280 and 310 nanometers, RayVio's XE Series enables high volume consumer UV disinfection and phototherapy solutions. The new XE Series makes its debut in Ellie. RayVio's XE Series is the smallest commercially available UV LED and can be easily incorporated into a broad range of consumer products from toothbrushes and baby bottle sterilizers to humidifiers and refrigerators. Because of the XE Series' output – more than 2 times that of similarly sized UV LEDs – battery life can be conserved and fewer emitters can be used in almost any solution. Unlike traditional ultraviolet light sources that are bulky, fragile and contain mercury, RayVio's XE Series is a compact, digital source that is safer than conventional sources and propels the transition from analog light to digital lighting applications that allow for connectivity, efficiency and mobility. RayVio XE Series at a Glance: Wavelength (Typ.) is 280nm, 310nm. Power output is about 1mW to 6mW. Current (Max) is 150mA. Lifetime (Typ.) is 1,500 hrs. Form Factors is 3,535 Emitter Star Board. The emitter version of the XE Series is a surface mount device that can be assembled using industry standard pick and place equipment. The Star Board option consists of an emitter mounted on to a metal core PCB that simplifies prototyping and offers higher thermal capabilities. Ultraviolet light with a wavelength of 280 nanometers from RayVio's XE Series protects against germs in water, air and on surfaces. At 310 nanometers, UV light from the XE Series can aid in treating skin diseases including psoriasis, eczema, rickets and jaundice. RayVio's ultraviolet LED portfolio consists of the XE Series and the XP Series. The XP Series is the industry's most powerful ultraviolet LED in a standard 6,565 package that can also be mounted on a Star Board. The XP Series is intended for applications that require higher outputs up to 60mW per emitter.
RayVio Corp. Announces Study Results from Efficacy Testing of its Deep Ultraviolet (UV) LED Solution for Disinfection
Jul 6 16
RayVio Corp. announced study results from efficacy testing of its deep ultraviolet (UV) LED solution for disinfection. The study shows that the company's deep UV LEDs can eliminate bacteria found in hospitals and homes more quickly and to a higher degree than today's most common disinfection products, aiding in the fight against hospital acquired infections (HAI). A single RayVio UV LED killed 99.9999% of the bacteria samples of Methicillin-resistant Staphylococcus aureus (MRSA), listeria and salmonella within 60 seconds. Even faster results or larger scale applications are enabled by using multiple LEDs. Researchers irradiated samples of bacteria with the company's deep UV LED emission wavelength of 285 nanometers at a 10 millimeter distance. They measured the change in bacteria population after time intervals between 5, and 80 seconds. 99.99% bacteria were killed in 5 seconds and 99.9999% killed within 60 seconds. The study was conducted at AEMTEK, a third party laboratory accredited by the American Association for Laboratory Accreditation (A2LA), which is recognized by the Food & Drug Administration (FDA).
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking
Most Searched Private Companies
Sponsored Financial Commentaries